TranS1 Inc. Announces Participation at the 2012 Piper Jaffray Healthcare Conference
14 Noviembre 2012 - 3:30PM
TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President
and Chief Executive Officer, and Joe Slattery, Executive Vice
President and Chief Financial Officer, are scheduled to present at
the 2012 Piper Jaffray Healthcare Conference in New York, NY on
Wednesday, November 28, 2012 at 2:00 pm ET. Institutional investors
that wish to request a meeting with TranS1 should contact Piper
Jaffray.
About TranS1 Inc.
TranS1 is a medical device company focused on designing,
developing and marketing products to treat degenerative conditions
of the spine affecting the lower lumbar region. TranS1 currently
markets the AxiaLIF® family of products for single and two level
lumbar fusion, the VEOTM lateral access and interbody fusion system
and the VectreTM posterior fixation system for lumbar fixation
supplemental to AxiaLIF fusion. TranS1 was founded in May 2000 and
is headquartered in Wilmington, North Carolina. For more
information, visit www.trans1.com.
CONTACT: Investors:
TranS1 Inc.
Joseph P. Slattery, 910-332-1700
Executive Vice-President and Chief Financial Officer
Westwicke Partners
Mark Klausner, 443-213-0501
trans1@westwicke.com
Baxano Surgical, Inc. (MM) (NASDAQ:TSON)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Baxano Surgical, Inc. (MM) (NASDAQ:TSON)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Baxano Surgical, Inc. (MM) (NASDAQ): 0 recent articles
Más de TranS1 Inc. Artículos de Noticias